Try our mobile app

Published: 2022-07-28 11:03:34 ET
<<<  go to GRFS company page
6-K 1 tm2221986d2_6k.htm FORM 6-K

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 6-K

 

REPORT OF FOREIGN ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF THE
SECURITIES EXCHANGE ACT OF 1934

 

For the month July 2022

 

(Commission File No. 001-35193)

 

Grifols, S.A.

(Translation of registrant’s name into English)

 

 

 

Avinguda de la Generalitat, 152-158

Parc de Negocis Can Sant Joan

Sant Cugat del Valles 08174

Barcelona, Spain

(Address of registrant’s principal executive office)

 

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F x  Form 40-F ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101 (b) (1):

 

Yes ¨  No x

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101 (b) (7):

 

Yes ¨  No x

 

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

 

Yes ¨  No x

 

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-

 

 

 

 

  

Grifols, S.A.

 

TABLE OF CONTENTS

 

Item   Sequential Page Number
     
1. Other Relevant Information, dated July 28, 2022 3

 

2 

 

GRAPHIC

Grifols, S.A. Avinguda de la Generalitat 152-158 08174 Sant Cugat del Vallès Barcelona - ESPAÑA Tel. [34] 935 710 500 Fax [34] 935 710 267 www.grifols.com Pursuant to the provisions of article 227 of the Consolidated Text of the Securities Market Act, approved by the Legislative Royal Decree 4/2015, of 23 October, Grifols, S.A. ("Grifols") hereby informs about the following OTHER RELEVANT INFORMATION Grifols informs that it has formalised the sale of substantially all of the assets of the business of its US subsidiary Goetech LLC, whose trade name is MedKeeper ("MedKeeper"), to affiliates of the US company Becton, Dickinson and Company for a purchase price of approximately US$ 93 million. MedKeeper develops and markets software applications based on web and mobile platforms for hospital pharmacy and was fully acquired by Grifols in 2020 when it exercised the call option on the remaining 49% of Medkeeper's share capital, having formalised the purchase of 51% of the share capital in 2018. This transaction is part of the divestment plan for non-strategic activities announced by Grifols, in line with its long-term sustainable growth strategy. In Barcelona, on 28 July 2022 Ms. Núria Martín Barnés Secretary to the Board of Directors

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.

 

  Grifols, S.A.
     
  By: /s/ David I. Bell
    Name: David I. Bell
    Title: Authorized Signatory

 

Date:  July 28, 2022

 

4